Glycogen Regulation and Functional Role in Mouse White Matter

Authors

  • Angus M. Brown,

    Corresponding author
    1. Department of Neurology, Box 356465, 1959 Pacific St N.E., University of Washington School of Medicine, Seattle, WA 98195, USA
    • Corresponding author
      A. M. Brown: MRC Applied Neuroscience Group, Biomedical Sciences, University of Nottingham, Queens Medical Centre, Nottingham NG7 2UH, UK. Email: ambrown@nottingham.ac.uk

    Search for more papers by this author
  • Selva Baltan Tekkök,

    1. Department of Neurology, Box 356465, 1959 Pacific St N.E., University of Washington School of Medicine, Seattle, WA 98195, USA
    Search for more papers by this author
  • Bruce R. Ransom

    1. Department of Neurology, Box 356465, 1959 Pacific St N.E., University of Washington School of Medicine, Seattle, WA 98195, USA
    Search for more papers by this author

Abstract

CNS glycogen, contained predominantly in astrocytes, can be converted to a monocarboxylate and transported to axons as an energy source during aglycaemia. We analysed glycogen regulation and the role of glycogen in supporting neural activity in adult mouse optic nerve, a favourable white matter preparation. Axon function was quantified by measuring the compound action potential (CAP) area. During aglycaemia, axon function persisted for 20 min, then declined in conjunction with glycogen content. Lactate fully supported CAPs in the absence of glucose, but was unable to sustain glycogen content; thus, axon failure occurred rapidly when lactate was withdrawn. Glycogen content in the steady state was directly proportional to bath glucose concentration. Increasing [K+]o to 10 mm caused a rapid decrease in glycogen content. Latency to onset of CAP failure during aglycaemia was directly proportional to glycogen content and varied from about 2 to 30 min. Intense neural activity reduced glycogen content in the presence of 10 mm bath glucose and CAP area gradually declined. CAP area declined more rapidly during high frequency stimulation if monocarboxylate transport was inhibited. This suggested that astrocytic glycogen was broken down to a monocarboxylate(s) that was used by rapidly discharging axons. Likewise, depleting glycogen by brief periods of high frequency axon stimulation accelerated onset of CAP decline during aglycaemia. In summary, these experiments indicated that glycogen content was under dynamic control and that glycogen was used to support the energy needs of CNS axons during both physiological as well as pathological processes.

Ancillary